A 29-year-old woman without HIV risk factors asks about HIV prevention for her partner, a man who has sex with men with multiple partners. Which is an...

Question

A 29-year-old woman without HIV risk factors asks about HIV prevention for her partner, a man who has sex with men with multiple partners. Which is an evidence-based PrEP option for at-risk individuals?

Accepted Answer

Daily emtricitabine/tenofovir disoproxil fumarate (TDF/FTC)

Answer

Daily emtricitabine/tenofovir alafenamide (TAF/FTC) for receptive vaginal sex

Answer

Long-acting cabotegravir injections every 12 months

Answer

Event-driven (2-1-1) TDF/FTC in cisgender women

Answer

Daily lopinavir/ritonavir

us-abfm MCQ (SBA): HIV PrEP

A 29-year-old woman without HIV risk factors asks about HIV prevention for her partner, a man who has sex with men with multiple partners. Which is an evidence-based PrEP option for at-risk individuals?